How High Novo Nordisk Could and Should Go for Ablynx Post author:Sam Post published:January 23, 2018 Post category:BioPharma Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved. Source: BioSpace You Might Also Like MorphoSys AG To Present At Upcoming Investor Conferences August 9, 2017 Celgene Crashed After Follicular Lymphoma Regimen Failed Phase III December 21, 2017 Charleston Laboratories Announces Senior Global Regulatory Hire February 14, 2017